Nurse and pharmacist systemic anti‐cancer therapy review clinics and their impact on patient experience and care: A systematic review

L Barrott, T Wiseman, V Tsianakas… - Journal of Advanced …, 2023 - Wiley Online Library
Aim To review the evidence of how nurse and pharmacist roles have been incorporated into
the management of patients undergoing systemic anti‐cancer therapy (SACT) services and …

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

SP Griffin, JR Signorelli, A Lasko… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction: This study was designed to describe the landscape of oncology pharmacy
practice at patient facing institutional healthcare organizations throughout the United States …

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and …

L Cuba, P Dürr, K Gessner, B Häcker, R Fietkau… - JCO Oncology …, 2024 - ascopubs.org
PURPOSE Implementation science endeavors to facilitate the translation of evidence-based
research into clinical routine. The clinical pharmacological/pharmaceutical care program …

Expanding oncology pharmacist teams: Justifying the return on investment

Z Mahmoudjafari, S Hough - Journal of Oncology Pharmacy …, 2022 - journals.sagepub.com
Oncology pharmacists are an integral member of the cancer care multi-disciplinary team.
Despite the role being previously well defined, responsibilities continue to expand. Position …

Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report

C Donzé, F Leenhardt, M Vinches, MC Eberlé… - Medicina, 2024 - mdpi.com
A 76-year-old female patient presented with an iodine-refractory papillary thyroid carcinoma
(PTC), diagnosed eight years earlier, with several lymph node recurrences requiring …

The clinical and financial impact of remote clinical oncology pharmacist engagement in community-based practices within The US Oncology Network

M Carroll, E Koselke, J Howell, J Cho… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction The integration of clinical oncology pharmacists into multidisciplinary healthcare
teams is not well-described in the community practice setting. This study aims to analyze the …

Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice

M Tsuchiya, D Kikuchi, S Hatakeyama… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Pharmacists are needed as members of oncology teams. The Japanese Society
of Hospital Pharmacists (JSHP) conducts a nationwide survey annually to analyze the actual …

Onco-pharmacist led evaluation of knowledge, attitude & practice (KAP) of safe handling cytotoxic drugs among health care professional's (HCP's) in tertiary care …

M Gudhoor, MS Ganachari, JK… - Journal of Oncology …, 2023 - journals.sagepub.com
Background Cytotoxic drugs (CDs) are hazardous in nature. But it is necessary for the
treatment in cancer patients. The healthcare professionals (HCPs) act as a facilitator through …

Evaluating hematology/oncology clinical pharmacist activities via self-reported work sampling

JS Lee, NA Nickman, M Pace - American Journal of Health …, 2022 - academic.oup.com
Purpose Hematology/oncology clinical pharmacists' work activities have been described in
previous literature, but time spent on pharmacist tasks has not been well characterized …

Patient and caregiver experience with telepharmacy in cancer care to support beginning systemic therapy: A qualitative study

OT Nguyen, A Mason, D Charles… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Although the COVID-19 pandemic spurred telehealth adoption for many
specialties and care team roles, the patient and caregiver experience for telepharmacy visits …